skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sequence-specific sup 1 H and sup 15 N resonance assignments for human dihydrofolate reductase in solution

Journal Article · · Biochemistry; (United States)
DOI:https://doi.org/10.1021/bi00116a031· OSTI ID:5688133
; ;  [1]; ; ;  [2]
  1. Harvard Medical School, Boston, MA (United States)
  2. Medical Coll. of Ohio, Toledo (United States)

Dihydrofolate reductase is an intracellular target enzyme for folate antagonists, including the anticancer drug methotrexate. In order to design novel drugs with altered binding properties, a detailed description of protein-drug interactions in solution is desirable to understand the specificity of drug binding. As a first step in this process, heteronuclear three-dimensional NMR spectroscopy has been used to make sequential resonance assignments for more than 90% of the residues in human dihydrofolate reductase complexed with methotrexate. Uniform enrichment of the 21.5-kDa protein with {sup 15}N was required to obtain the resonance assignments via heteronuclear 3D NMR spectroscopy since homonuclear 2D spectra did not provide sufficient {sup 1}H resonance dispersion. Medium- and long-range NOE's have been used to characterize the secondary structure of the binary ligand-enzyme complex in solution.

OSTI ID:
5688133
Journal Information:
Biochemistry; (United States), Vol. 31:1; ISSN 0006-2960
Country of Publication:
United States
Language:
English